1000-Gallon Pivoting Triple Shaft Mixer

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-10-02-2020
Volume 44
Issue 10
Pages: 12

The ROSS VMC-1000 VersaMix is a 1000-gallon triple-shaft mixer available on a pivot-design single-post hydraulic lift.

The ROSS VMC-1000 VersaMix is a 1000-gallon triple-shaft mixer available on a pivot-design single-post hydraulic lift. The new design allows the machine to be raised from a vessel, rotate 90 degrees, and lowered into another vessel, which allows for convenient discharge of finished product in the first vessel while a new batch is being made in the second. By reducing overall processing time and minimizing downtime, the pivoting mixer saves time and money while simplifying the mixing, discharging, and cleaning operations, according to the company. The mixer is available across a full range of working capacities, from 1 quart to 2000 gallons.

​​ Charles Ross & Son Company​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Download Issue PDF
Articles in this issue
Unique Molecules Push Formulation Boundaries
Unique Molecules Push Formulation Boundaries
Development of a Validated Method of Testing for NDMA in Ranitidine
Development of a Validated Method of Testing for NDMA in Ranitidine
TANYA78 - STOCK.ADOBE.COM
Masking Taste: A Key Attribute to Success
Mikhaylovskiy - stock.adobe.com
Factoring Stability in the Biologic Drug Mix
Improving Agility Through Scalability
Improving Agility Through Scalability
Panupat/stock.adobe.com—cell culture flask in the light
Modernizing Bioprocessing for Gene Therapy Viral Vectors
Scaling Up Fast
Scaling Up Fast
3DKOMBINAT - STOCK.ADOBE.COM
Viewpoint: Digitizing Processes to Align with GMP Requirements
PremiumStock - Stock.adobe.com
Unlocking the Key Changes to Annex 1
strategy for biologics manufacturing
Strategizing for Rapid Changeovers in Biologics Manufacturing
HOLMESSU - STOCK.ADOBE.COM
Securing the Pharmaceutical Supply Chain with Full Traceability
Cellular and Gene Therapies Face a Manufacturing Capacity Crunch
Cellular and Gene Therapies Face a Manufacturing Capacity Crunch
W.Scott McGill - stock.adobe.com
Will COVID-19 Pandemic Finally Establish Drug Quality Metrics?
Regulating with Flexibility: The Pandemic Effect
Fighting the (Dis)Information Pandemic
Recent Videos
Related Content
Text sign showing Industry News. Business photo text delivering news to the general public or a target public | Image Credit: © Artur - stock.adobe.com

Capsida Previews Its Oral and Poster Presentations for ASGCT 2025

Patrick Lavery
April 29th 2025
Article

The company’s exhibitions will be focused in the areas of its pipeline, proprietary capsid engineering, and manufacturing.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - stock.adobe.com

Roche to Invest $50 Billion in US Pharmaceuticals and Diagnostics

Patrick Lavery
April 22nd 2025
Article

The commitment will include new, state-of-the-art R&D facilities as well as new or expanded manufacturing sites in multiple states.

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
April 30th 2024
Podcast

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

compounding pharmacist at work 2 | Image Credit: ©Nadia -stock.adobe.com

Pharmaceutical Compounding Calculations, Part One–Non-Salts, Salts, and Policy-Exception Salts

Paul L. Pluta;Nishant B. Thakar;Varanya Chaiyaperm
April 18th 2025
Article

Calculating the amount of drug needed for compounding requires different considerations for respective drug types and forms.

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact

Alicia Bigica
April 16th 2025
Article

On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.